{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:04:05Z","timestamp":1789679045111,"version":"4.0.1"},"reference-count":267,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015822","name":"Fondazione Roma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015822","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.mam.2023.101225","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T05:09:36Z","timestamp":1700802576000},"page":"101225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Novel frontiers in neuroprotective therapies in glaucoma: Molecular and clinical aspects"],"prefix":"10.1016","volume":"94","author":[{"given":"Alessandra","family":"Boccaccini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Cavaterra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Carnevale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Tanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Marini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Bocedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro M.","family":"Lacal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Manni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Graziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Sbardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia Raffaella","family":"Tundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mam.2023.101225_bib1","article-title":"Apolipoprotein \u03b5 in brain and retinal neurodegenerative diseases","author":"Abyadeh","year":"2023","journal-title":"Aging Dis"},{"key":"10.1016\/j.mam.2023.101225_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1089\/jop.2009.0100","article-title":"Effects of repeated administrations of tafluprost, latanoprost, and travoprost on optic nerve head blood flow in conscious normal rabbits","volume":"26","author":"Akaishi","year":"2010","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.mam.2023.101225_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev-vision-102016-061422","article-title":"Neuroprotection in glaucoma: animal models and clinical trials","volume":"3","author":"Almasieh","year":"2017","journal-title":"Annu Rev Vis Sci"},{"key":"10.1016\/j.mam.2023.101225_bib4","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.preteyeres.2011.11.002","article-title":"The molecular basis of retinal ganglion cell death in glaucoma","volume":"31","author":"Almasieh","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.mam.2023.101225_bib5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1139\/bcb-2018-0218","article-title":"Citicoline protects against lead-induced oxidative injury in neuronal PC12 cells","volume":"97","author":"Aminzadeh","year":"2019","journal-title":"Biochem. Cell. Biol."},{"key":"10.1016\/j.mam.2023.101225_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1167\/tvst.1.1.4","article-title":"Antioxidants protect trabecular meshwork cells from hydrogen peroxide-induced cell death","volume":"1","author":"Ammar","year":"2012","journal-title":"Trans. Vis. Sci. Tech."},{"key":"10.1016\/j.mam.2023.101225_bib7","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/antiox12010094","article-title":"Mechanisms underlying neurodegenerative disorders and potential neuroprotective activity of agrifood by-products","volume":"12","author":"Angeloni","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.mam.2023.101225_bib8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.preteyeres.2010.09.002","article-title":"Use of calcium channel blockers for glaucoma","volume":"30","author":"Araie","year":"2011","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.mam.2023.101225_bib9","doi-asserted-by":"crossref","first-page":"7290","DOI":"10.3390\/ijms21197290","article-title":"Retinal degeneration and Alzheimer's disease: an evolving link","volume":"21","author":"Ashok","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib10","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/ptr.1749","article-title":"Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents","volume":"19","author":"Assimopoulou","year":"2005","journal-title":"Phytother Res."},{"key":"10.1016\/j.mam.2023.101225_bib11","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.4103\/1673-5374.335834","article-title":"Neuroprotection and neuroregeneration: roles for the white matter","volume":"17","author":"Baldassarro","year":"2022","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.mam.2023.101225_bib12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0022-510X(03)00204-1","article-title":"Neuroprotective effect of citicoline in 6-hydroxydopamine-lesioned rats and in 6-hydroxydopamine-treated SH-SY5Y human neuroblastoma cells","volume":"215","author":"Barrachina","year":"2003","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0006-8993(02)03605-3","article-title":"Citicoline increases glutathione redox ratio and reduces caspase-3 activation and cell death in staurosporine-treated SH-SY5Y human neuroblastoma cells","volume":"957","author":"Barrachina","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.mam.2023.101225_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000047976","article-title":"High occurrence rate of glaucoma among patients with Alzheimer's disease","volume":"47","author":"Bayer","year":"2002","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.mam.2023.101225_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ajo.2021.11.002","article-title":"Phase 1b randomized controlled study of short course topical recombinant human nerve growth factor (rhNGF) for neuroenhancement in glaucoma: safety, tolerability, and efficacy measure outcomes","volume":"234","author":"Beykin","year":"2022","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ptr.814","article-title":"The antioxidant activity of standardized extract of Ginkgo biloba (EGb 761) in rats","volume":"15","author":"Bridi","year":"2001","journal-title":"Phytother Res."},{"key":"10.1016\/j.mam.2023.101225_bib17","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2460\/ajvr.1997.58.08.864","article-title":"Vitreous body glutamate concentration in dogs with glaucoma","volume":"58","author":"Brooks","year":"1997","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.mam.2023.101225_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.preteyeres.2004.06.001","article-title":"The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage","volume":"24","author":"Burgoyne","year":"2005","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.mam.2023.101225_bib19","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.preteyeres.2012.07.001","article-title":"Critical pathogenic events underlying progression of neurodegeneration in glaucoma","volume":"31","author":"Calkins","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.mam.2023.101225_bib20","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1517\/14656566.1.4.815","article-title":"The evolving pharmacotherapeutic profile of brimonidine, an alpha 2-adrenergic agonist, after four years of continuous use","volume":"1","author":"Cantor","year":"2000","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.mam.2023.101225_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/iovs.61.3.13","article-title":"Protection of the retinal ganglion cells: intravitreal injection of resveratrol in mouse model of ocular hypertension","volume":"61","author":"Cao","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224982","article-title":"Human vitreous concentrations of citicoline following topical application of citicoline 2% ophthalmic solution","volume":"14","author":"Carnevale","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2023.101225_bib23","first-page":"2633","article-title":"Vitreal glutamate concentration in monkeys with experimental glaucoma","volume":"43","author":"Carter-Dawson","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib24","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1007\/s10792-021-01959-y","article-title":"Serum and aqueous humor levels of brain-derived neurotrophic factor in patients with primary open-angle glaucoma and normal-tension glaucoma","volume":"41","author":"Cha","year":"2021","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/EB.S293765","article-title":"Glaucoma as neurodegeneration in the brain","volume":"13","author":"Chan","year":"2021","journal-title":"Eye Brain"},{"key":"10.1016\/j.mam.2023.101225_bib26","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ophtha.2011.11.003","article-title":"Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement","volume":"119","author":"Chang","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.mam.2023.101225_bib27","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ophtha.2011.11.003","article-title":"Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement","volume":"119","author":"Chang","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.mam.2023.101225_bib28","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0006-8993(98)00212-1","article-title":"MK801-a neuroprotectant in rat hypertensive eyes","volume":"792","author":"Chaudhary","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.mam.2023.101225_bib29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/15216549900201423","article-title":"Different effects of the constituents of EGb761 on apoptosis in rat cerebellar granule cells induced by hydroxyl radicals","volume":"47","author":"Chen","year":"1999","journal-title":"TBMB"},{"key":"10.1016\/j.mam.2023.101225_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1113\/jphysiol.1997.sp021909","article-title":"Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism","volume":"499","author":"Chen","year":"1997","journal-title":"J. Physiol."},{"key":"10.1016\/j.mam.2023.101225_bib31","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3389\/fnins.2017.00648","article-title":"Targeted delivery of mitochondrial calcium channel regulators: the future of glaucoma treatment?","volume":"11","author":"Cheung","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.mam.2023.101225_bib32","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1523\/JNEUROSCI.3986-15.2016","article-title":"Tau accumulation, altered phosphorylation, and missorting promote neurodegeneration in glaucoma","volume":"36","author":"Chiasseu","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mam.2023.101225_bib33","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2165\/00003495-200767050-00006","article-title":"Pharmacological neuroprotection for glaucoma","volume":"67","author":"Chidlow","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.mam.2023.101225_bib34","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.2174\/1570159X16666180419121247","article-title":"Glaucoma pathogenesis and neurotrophins: focus on the molecular and genetic basis for therapeutic prospects","volume":"16","author":"Chitranshi","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.mam.2023.101225_bib35","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ymthe.2018.09.019","article-title":"Loss of Shp2 rescues BDNF\/TrkB signaling and contributes to improved retinal ganglion cell neuroprotection","volume":"27","author":"Chitranshi","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mam.2023.101225_bib36","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1089\/jmf.2018.4350","article-title":"Neuroprotective effect of ginkgo biloba extract against hypoxic retinal ganglion cell degeneration in vitro and in vivo","volume":"22","author":"Cho","year":"2019","journal-title":"J. Med. Food"},{"key":"10.1016\/j.mam.2023.101225_bib37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1517\/17460441.2015.1000857","article-title":"Discovery of novel inhibitors for the treatment of glaucoma","volume":"10","author":"Cholkar","year":"2015","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.mam.2023.101225_bib38","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.2015.15629","article-title":"Statins for prevention of cardiovascular disease in adults: evidence report and systematic review for the US preventive services task force","volume":"316","author":"Chou","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.mam.2023.101225_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.00219","article-title":"The susceptibility of retinal ganglion cells to glutamatergic excitotoxicity is type-specific","volume":"13","author":"Christensen","year":"2019","journal-title":"Front. Neurosci."},{"issue":"Suppl. 1","key":"10.1016\/j.mam.2023.101225_bib40","article-title":"Risk factors for glaucoma onset and progression","volume":"53","author":"Coleman","year":"2008","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.705405","article-title":"Brimonidine is neuroprotective in animal paradigm of retinal ganglion cell damage","volume":"12","author":"Conti","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.mam.2023.101225_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49356-x","article-title":"Excitotoxic neurodegeneration is associated with a focal decrease in metabotropic glutamate receptor type 5 availability: an in vivo PET imaging study","volume":"9","author":"Crabb\u00e9","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mam.2023.101225_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2010.12.036","article-title":"Neurodegeneration in glaucoma: progression and calcium-dependent intracellular mechanisms","volume":"176","author":"Crish","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.mam.2023.101225_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.preteyeres.2014.07.001","article-title":"Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases","volume":"43","author":"Cuenca","year":"2014","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.mam.2023.101225_bib46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40035-017-0096-2","article-title":"Disease modification and Neuroprotection in neurodegenerative disorders","volume":"6","author":"Cummings","year":"2017","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.mam.2023.101225_bib47","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.bbamem.2006.12.015","article-title":"Cellular and molecular effects of unoprostone as a BK channel activator","volume":"1768","author":"Cuppoletti","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mam.2023.101225_bib48","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.drudis.2010.02.007","article-title":"Strategies for optic nerve rescue and regeneration in glaucoma and other optic neuropathies","volume":"15","author":"Dahlmann-Noor","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.mam.2023.101225_bib49","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3174\/ajnr.A2486","article-title":"Assessment of lateral geniculate nucleus atrophy with 3T MR imaging and correlation with clinical stage of glaucoma","volume":"32","author":"Dai","year":"2011","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.mam.2023.101225_bib50","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2415-13-26","article-title":"Brimonidine protects against loss of Thy-1 promoter activation following optic nerve crush","volume":"13","author":"Dai","year":"2013","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib51","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ajo.2009.03.029","article-title":"Neuroprotection: extrapolating from neurologic diseases to the eye","volume":"148","author":"Danesh-Meyer","year":"2009","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/jamaophthalmol.2021.4576","article-title":"Nicotinamide and pyruvate for neuroenhancement in open-angle glaucoma","volume":"140","author":"De Moraes","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.mam.2023.101225_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142067","article-title":"Tackling glaucoma from within the brain: an unfortunate interplay of BDNF and TrkB","volume":"10","author":"Dekeyster","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2023.101225_bib54","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s40478-018-0650-x","article-title":"Amyloid-beta and phosphorylated tau in post-mortem Alzheimer's disease retinas","volume":"6","author":"den Haan","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.mam.2023.101225_bib55","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3390\/antiox9040279","article-title":"Ginkgo biloba prevents oxidative stress-induced apoptosis blocking p53 activation in neuroblastoma cells","volume":"9","author":"Di Meo","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.mam.2023.101225_bib56","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.3390\/ijms23073935","article-title":"The role of axonal transport in glaucoma","volume":"23","author":"Dias","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib57","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1038\/s41467-022-34443-x","article-title":"Ciliary neurotrophic factor-mediated neuroprotection involves enhanced glycolysis and anabolism in degenerating mouse retinas","volume":"13","author":"Do Rhee","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2023.101225_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115579","article-title":"Rescue of retinal function by BDNF in a mouse model of glaucoma","volume":"9","author":"Domenici","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2023.101225_bib59","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1167\/iovs.08-2078","article-title":"Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity","volume":"49","author":"Dong","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib60","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4103\/2008-322X.183923","article-title":"Neuroprotection in glaucoma","volume":"11","author":"Doozandeh","year":"2016","journal-title":"J. Ophthalmic Vis. Res."},{"key":"10.1016\/j.mam.2023.101225_bib61","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/archopht.1996.01100130295012","article-title":"Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma","volume":"114","author":"Dreyer","year":"1996","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib62","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2147\/DDDT.S352876","article-title":"Efficacy of nimodipine combined with latanoprost in treating open-angle glaucoma and its influence on ocular hemodynamics and visual field defects","volume":"16","author":"Duan","year":"2022","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.mam.2023.101225_bib63","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/4581909","article-title":"Neuroinflammatory mechanisms of mitochondrial dysfunction and neurodegeneration in glaucoma","volume":"2021","author":"Duarte","year":"2021","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.mam.2023.101225_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2010.09.005","article-title":"Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis","volume":"93","author":"Dutta","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.mam.2023.101225_bib65","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-009-0532-1","article-title":"Classification and basic pathology of Alzheimer disease","volume":"118","author":"Duyckaerts","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.mam.2023.101225_bib66","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1196\/annals.1352.023","article-title":"Stabilization of mitochondrial membrane potential and improvement of neuronal energy metabolism by ginkgo biloba extract EGb 761","volume":"1056","author":"Eckert","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib67","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/bjo.2003.032110","article-title":"Ocular blood flow alteration in glaucoma is related to systemic vascular dysregulation","volume":"88","author":"Emre","year":"2004","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib68","first-page":"1","article-title":"European glaucoma society Terminology and Guidelines for glaucoma","volume":"105","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib69","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1038\/s41598-018-22848-y","article-title":"Assessment of intrinsic and extrinsic signaling pathway in excitotoxic retinal ganglion cell death","volume":"8","author":"Fahrenthold","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mam.2023.101225_bib70","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2202-11-31","article-title":"Neuroprotective effects of bis(7)-tacrine against glutamate-induced retinal ganglion cells damage","volume":"11","author":"Fang","year":"2010","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.mam.2023.101225_bib71","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10522-012-9409-0","article-title":"Safranal ameliorates antioxidant enzymes and suppresses lipid peroxidation and nitric oxide formation in aged male rat liver","volume":"14","author":"Farahmand","year":"2013","journal-title":"Biogerontology"},{"key":"10.1016\/j.mam.2023.101225_bib72","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1167\/iovs.16-19825","article-title":"Long-term protection of retinal ganglion cells and visual function by brain-derived neurotrophic factor in mice with ocular hypertension","volume":"57","author":"Feng","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib73","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.3390\/ijms20174110","article-title":"Neuroprotective and anti-inflammatory effects of a hydrophilic saffron extract in a model of glaucoma","volume":"20","author":"Fern\u00e1ndez-Albarral","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043074","article-title":"Safranal, a saffron constituent, attenuates retinal degeneration in P23H rats","volume":"7","author":"Fern\u00e1ndez-S\u00e1nchez","year":"2012","journal-title":"PLoS One"},{"issue":"Suppl. 2","key":"10.1016\/j.mam.2023.101225_bib75","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1016\/j.survophthal.2007.08.012","article-title":"What is the present pathogenetic concept of glaucomatous optic neuropathy?","volume":"52","author":"Flammer","year":"2007","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib76","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1350-9462(02)00008-3","article-title":"The impact of ocular blood flow in glaucoma","volume":"21","author":"Flammer","year":"2002","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.mam.2023.101225_bib77","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1517\/13543784.2011.579901","article-title":"Medical treatment of glaucoma: present and future","volume":"20","author":"Fogagnolo","year":"2011","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.mam.2023.101225_bib78","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.preteyeres.2018.04.001","article-title":"The coma in glaucoma: retinal ganglion cell dysfunction and recovery","volume":"65","author":"Fry","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.mam.2023.101225_bib79","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1136\/bjo.2005.067637","article-title":"Effect of dorzolamide and timolol on ocular blood flow in patients with primary open angle glaucoma and ocular hypertension","volume":"89","author":"Fuchsj\u00e4ger-Mayrl","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib80","doi-asserted-by":"crossref","first-page":"e763","DOI":"10.1038\/cddis.2013.298","article-title":"Brimonidine promotes axon growth after optic nerve injury through Erk phosphorylation","volume":"4","author":"Fujita","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mam.2023.101225_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2019.03.001","article-title":"Photoreceptor cell replacement in macular degeneration and retinitis pigmentosa: a pluripotent stem cell-based approach","volume":"71","author":"Gagliardi","year":"2019","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.mam.2023.101225_bib82","first-page":"117","article-title":"Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension","volume":"3","author":"Galanopoulos","year":"2009","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib83","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/archopht.120.6.797","article-title":"Up-regulation of brain-derived neurotrophic factor expression by brimonidine in rat retinal ganglion cells","volume":"120","author":"Gao","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib84","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.archger.2014.10.011","article-title":"Abnormal retinal nerve fiber layer thickness and macula lutea in patients with mild cognitive impairment and Alzheimer's disease","volume":"60","author":"Gao","year":"2015","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.mam.2023.101225_bib85","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/brainsci8120222","article-title":"The genetic diagnosis of neurodegenerative diseases and therapeutic perspectives","volume":"8","author":"Garc\u00eda","year":"2018","journal-title":"Brain Sci."},{"key":"10.1016\/j.mam.2023.101225_bib86","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(14)62111-5","article-title":"Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial","volume":"385","author":"Garway-Heath","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.mam.2023.101225_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2023.100298","article-title":"Phase I NT-501 ciliary neurotrophic factor implant trial for primary open-angle glaucoma: safety, neuroprotection, and neuroenhancement","volume":"3","author":"Goldberg","year":"2023","journal-title":"Ophthalmology Science"},{"key":"10.1016\/j.mam.2023.101225_bib88","doi-asserted-by":"crossref","first-page":"xxiv","DOI":"10.1016\/j.ajo.2018.02.016","article-title":"What we have learned from the ocular hypertension treatment study","volume":"189","author":"Gordon","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib89","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.icu.0000156134.38495.0b","article-title":"Blood flow in glaucoma","volume":"16","author":"Grieshaber","year":"2005","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib90","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nm723","article-title":"HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration","volume":"8","author":"Grimm","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.mam.2023.101225_bib91","first-page":"722","article-title":"Effects of betaxolol on light responses and membrane conductance in retinal ganglion cells","volume":"41","author":"Gross","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib92","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ifset.2009.07.002","article-title":"Antioxidant properties of resveratrol: a structure\u2013activity insight","volume":"11","author":"G\u00fcl\u00e7in","year":"2010","journal-title":"Innovat. Food Sci. Emerg. Technol."},{"key":"10.1016\/j.mam.2023.101225_bib93","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1167\/iovs.05-0754","article-title":"Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo","volume":"47","author":"Guo","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib94","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3129\/i07-185","article-title":"Retinal tau pathology in human glaucomas","volume":"43","author":"Gupta","year":"2008","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib95","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/ICU.0b013e3280895aea","article-title":"Glaucoma as a neurodegenerative disease","volume":"18","author":"Gupta","year":"2007","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100899","article-title":"Retinal changes in Alzheimer's disease- integrated prospects of imaging, functional and molecular advances","volume":"82","author":"Gupta","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.mam.2023.101225_bib97","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/ceo.13336","article-title":"Neuroprotection in glaucoma: recent advances and clinical translation","volume":"47","author":"Guymer","year":"2019","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib98","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/ceo.13336","article-title":"Neuroprotection in glaucoma: recent advances and clinical translation","volume":"47","author":"Guymer","year":"2019","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114781","article-title":"Gene therapy strategies for glaucoma from IOP reduction to retinal neuroprotection: progress towards non-viral systems","volume":"196","author":"Hakim","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mam.2023.101225_bib100","doi-asserted-by":"crossref","first-page":"33619","DOI":"10.1073\/pnas.2014213117","article-title":"Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin","volume":"117","author":"Harder","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mam.2023.101225_bib101","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nn835","article-title":"Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways","volume":"5","author":"Hardingham","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.mam.2023.101225_bib102","doi-asserted-by":"crossref","first-page":"S284","DOI":"10.1016\/S0039-6257(01)00200-4","article-title":"Efficacy and safety of memantine, an NMDA-type open-channel blocker, for reduction of retinal injury associated with experimental glaucoma in rat and monkey","volume":"45","author":"Hare","year":"2001","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib103","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00401-016-1613-6","article-title":"Ocular indicators of Alzheimer's: exploring disease in the retina","volume":"132","author":"Hart","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.mam.2023.101225_bib104","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1523\/JNEUROSCI.3652-17.2018","article-title":"Structural and functional rescue of chronic metabolically stressed optic nerves through respiration","volume":"38","author":"Harun-Or-Rashid","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mam.2023.101225_bib105","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0161-6420(98)91133-2","article-title":"The probability of blindness from open-angle glaucoma","volume":"105","author":"Hattenhauer","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.mam.2023.101225_bib106","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.exer.2008.02.008","article-title":"Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments","volume":"86","author":"Hern\u00e1ndez","year":"2008","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.mam.2023.101225_bib107","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/13543784.2021.1896701","article-title":"Investigational neuroprotective compounds in clinical trials for retinal disease","volume":"30","author":"Hill","year":"2021","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.mam.2023.101225_bib108","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM198608213150804","article-title":"Optic-nerve degeneration in Alzheimer's disease","volume":"315","author":"Hinton","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mam.2023.101225_bib109","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1076\/ceyr.28.3.153.26246","article-title":"The Ginkgo biloba extract (EGb 761) provides a neuroprotective effect on retinal ganglion cells in a rat model of chronic glaucoma","volume":"28","author":"Hirooka","year":"2004","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.mam.2023.101225_bib110","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.expneurol.2012.01.014","article-title":"Intrinsic axonal degeneration pathways are critical for glaucomatous damage","volume":"246","author":"Howell","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.mam.2023.101225_bib111","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1080\/02713683.2021.1944645","article-title":"Effect of nimodipine on macular and peripapillary capillary vessel density in patients with normal-tension glaucoma using optical coherence tomography angiography","volume":"46","author":"Hu","year":"2021","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.mam.2023.101225_bib112","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/IJG.0b013e3181b4cac7","article-title":"Serum cytokine alteration is associated with optic neuropathy in human primary open angle glaucoma","volume":"19","author":"Huang","year":"2010","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.mam.2023.101225_bib113","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1177\/1120672120960337","article-title":"Effect of dietary modification and antioxidant supplementation on intraocular pressure and open-angle glaucoma","volume":"31","author":"Jabbehdari","year":"2021","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib114","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.0953-816X.2003.03107.x","article-title":"CNTF promotes survival of retinal ganglion cells after induction of ocular hypertension in rats: the possible involvement of STAT3 pathway","volume":"19","author":"Ji","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.mam.2023.101225_bib115","first-page":"808","article-title":"Neurotrophin roles in retinal ganglion cell survival: lessons from rat glaucoma models","volume":"88","author":"Johnson","year":"2009","journal-title":"Experimental Eye Research, Current aspects of aqueous humor dynamics and glaucoma"},{"key":"10.1016\/j.mam.2023.101225_bib116","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ejphar.2015.08.035","article-title":"\u03b12-Adrenergic modulation of the glutamate receptor and transporter function in a chronic ocular hypertension model","volume":"765","author":"Jung","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.mam.2023.101225_bib117","first-page":"320734","article-title":"Association between statin use and rates of structural and functional loss in glaucoma","volume":"2021","author":"Kang","year":"2022","journal-title":"Br J Ophthalmol bjophthalmol"},{"key":"10.1016\/j.mam.2023.101225_bib118","first-page":"493","article-title":"Glaucoma","volume":"105","author":"Kang","year":"2021","journal-title":"Med. Clin."},{"key":"10.1016\/j.mam.2023.101225_bib119","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3390\/ijms23010386","article-title":"The role of inflammation in retinal neurodegeneration and degenerative diseases","volume":"23","author":"Kaur","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib120","first-page":"741","article-title":"Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons","volume":"41","author":"Kerrigan-Baumrind","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib121","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/eye.2016.299","article-title":"Protecting retinal ganglion cells","volume":"31","author":"Khatib","year":"2017","journal-title":"Eye"},{"key":"10.1016\/j.mam.2023.101225_bib122","article-title":"Neuroprotective effect of statins in a rat model of chronic ocular hypertension","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib123","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s001250051536","article-title":"Safety of high-dose nicotinamide: a review","volume":"43","author":"Knip","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.mam.2023.101225_bib124","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0306-4522(01)00557-7","article-title":"Neurturin enhances the survival of axotomized retinal ganglion cells in vivo: combined effects with glial cell line-derived neurotrophic factor and brain-derived neurotrophic factor","volume":"110","author":"Koeberle","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.mam.2023.101225_bib125","doi-asserted-by":"crossref","first-page":"7935","DOI":"10.1038\/s41598-023-35020-y","article-title":"Differences in optic nerve head structure between acute angle-closure glaucoma and open-angle glaucoma","volume":"13","author":"Kong","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mam.2023.101225_bib126","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93621","article-title":"Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease","volume":"2","author":"Koronyo","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.mam.2023.101225_bib127","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.ophtha.2008.05.015","article-title":"A placebo-controlled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure","volume":"115","author":"Koseki","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.mam.2023.101225_bib128","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00061198-199904000-00006","article-title":"Effects of oral brovincamine on visual field damage in patients with normal-tension glaucoma with low-normal intraocular pressure","volume":"8","author":"Koseki","year":"1999","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.mam.2023.101225_bib129","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1167\/iovs.19-27099","article-title":"Nicotinamide deficiency in primary open-angle glaucoma","volume":"60","author":"Kouassi Nzoughet","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib131","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/ceo.14218","article-title":"From bench to behaviour: the role of lifestyle factors on intraocular pressure, neuroprotection, and disease progression in glaucoma","volume":"51","author":"Kumar","year":"2023","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib132","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.3390\/jpm12111884","article-title":"Neuroprotection in glaucoma: basic aspects and clinical relevance","volume":"12","author":"Kuo","year":"2022","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.mam.2023.101225_bib133","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.exer.2010.09.004","article-title":"Effects of prostaglandin F(2\u03b1) analogues on endothelin-1-induced impairment of rabbit ocular blood flow: comparison among tafluprost, travoprost, and latanoprost","volume":"91","author":"Kurashima","year":"2010","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.mam.2023.101225_bib134","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1017\/S1041610217000801","article-title":"Glaucoma may be a non-memory manifestation of Alzheimer's disease in older people","volume":"29","author":"Lai","year":"2017","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.mam.2023.101225_bib135","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.3390\/ijms24032985","article-title":"Erythropoietin in glaucoma: from mechanism to therapy","volume":"24","author":"Lai","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib136","doi-asserted-by":"crossref","first-page":"13469","DOI":"10.1073\/pnas.0906678106","article-title":"Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: implications for glaucoma","volume":"106","author":"Lambiase","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mam.2023.101225_bib137","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.875662","article-title":"Brain-derived neurotrophic factor-mediated neuroprotection in glaucoma: a review of current state of the art","volume":"13","author":"Lambuk","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.mam.2023.101225_bib138","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.survophthal.2017.09.010","article-title":"Glaucoma and the brain: trans-synaptic degeneration, structural change, and implications for neuroprotection","volume":"63","author":"Lawlor","year":"2018","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib139","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4103\/1673-5374.346546","article-title":"Neuroprotective effects of exogenous brain-derived neurotrophic factor on amyloid-beta 1\u201340-induced retinal degeneration","volume":"18","author":"Lazaldin","year":"2023","journal-title":"Neural Regeneration Research"},{"key":"10.1016\/j.mam.2023.101225_bib140","article-title":"Brimonidine blocks glutamate excitotoxicity-induced oxidative stress and preserves mitochondrial transcription factor a in ischemic retinal injury","volume":"7","author":"Lee","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2023.101225_bib141","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1167\/iovs.13-12564","article-title":"Coenzyme Q10 inhibits glutamate excitotoxicity and oxidative stress\u2013mediated mitochondrial alteration in a mouse model of glaucoma","volume":"55","author":"Lee","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib142","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00055735-200404000-00008","article-title":"Factors for progression and glaucoma treatment: the early manifest glaucoma trial","volume":"15","author":"Leske","year":"2004","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib143","first-page":"246","article-title":"Neuroprotection in optic neuropathy","volume":"7","author":"Levin","year":"2018","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.mam.2023.101225_bib144","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.964197","article-title":"Neuroprotection in neurodegenerations of the brain and eye: lessons from the past and directions for the future","volume":"13","author":"Levin","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.mam.2023.101225_bib145","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s11033-022-08102-9","article-title":"Crocetin confers neuroprotection and is anti-inflammatory in rats with induced glaucoma","volume":"50","author":"Li","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.mam.2023.101225_bib146","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.3390\/biom11081215","article-title":"Retinal dysfunction in Alzheimer's disease and implications for biomarkers","volume":"11","author":"Liao","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.mam.2023.101225_bib147","article-title":"Glaucoma, Alzheimer's disease, and Parkinson's disease: an 8-year population-based follow-up study","volume":"9","author":"Lin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2023.101225_bib148","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232416038","article-title":"The latest evidence of erythropoietin in the treatment of glaucoma","volume":"23","author":"Lin","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib150","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/sj.eye.6701623","article-title":"Glutamate excitotoxicity in glaucoma: truth or fiction?","volume":"19","author":"Lotery","year":"2005","journal-title":"Eye"},{"key":"10.1016\/j.mam.2023.101225_bib151","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.fct.2008.10.029","article-title":"Resveratrol prevents the expression of glaucoma markers induced by chronic oxidative stress in trabecular meshwork cells","volume":"47","author":"Luna","year":"2009","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.mam.2023.101225_bib152","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1755-3768.2008.01486.x","article-title":"The effect of ginkgo biloba on the rat retinal ganglion cell survival in the optic nerve crush model","volume":"88","author":"Ma","year":"2010","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib153","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00055735-200312000-00006","article-title":"Neuroprotection in glaucoma: a model for neuroprotection in optic neuropathies","volume":"14","author":"Marcic","year":"2003","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib154","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.neuron.2022.03.004","article-title":"ApoE Cascade Hypothesis in the pathogenesis of Alzheimer's disease and related dementias","volume":"110","author":"Martens","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.mam.2023.101225_bib155","doi-asserted-by":"crossref","first-page":"631","DOI":"10.5811\/westjem.2018.4.38383","article-title":"Understanding the use of composite endpoints in clinical trials","volume":"19","author":"McCoy","year":"2018","journal-title":"West. J. Emerg. Med."},{"key":"10.1016\/j.mam.2023.101225_bib156","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ophtha.2005.06.020","article-title":"Results of the European glaucoma prevention study","volume":"112","author":"Miglior","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.mam.2023.101225_bib157","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2949102","article-title":"Neuroprotection in neurodegenerative disease: from basic science to clinical applications","volume":"2017","author":"Monteiro","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.mam.2023.101225_bib158","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29557-6","article-title":"Association between open-angle glaucoma and the risks of Alzheimer's and Parkinson's diseases in South Korea: a 10-year nationwide cohort study","volume":"8","author":"Moon","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mam.2023.101225_bib159","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1442-9071.2012.02789.x","article-title":"Retina ganglion cell degeneration in glaucoma: an opportunity missed? A review: RGC degeneration","volume":"40","author":"Morgan","year":"2012","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib160","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.mcn.2009.03.002","article-title":"Exogenous CNTF stimulates axon regeneration of retinal ganglion cells partially via endogenous CNTF","volume":"41","author":"M\u00fcller","year":"2009","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.mam.2023.101225_bib161","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3390\/life13051120","article-title":"Nutritional factors: benefits in glaucoma and ophthalmologic pathologies","volume":"13","author":"Musa","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.mam.2023.101225_bib162","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/17469899.2017.1259566","article-title":"Role of BDNF\/TrkB pathway in the visual system: therapeutic implications for glaucoma","volume":"12","author":"Mysona","year":"2017","journal-title":"Expet Rev. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib163","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.exer.2006.05.018","article-title":"Latanoprost rescues retinal neuro-glial cells from apoptosis by inhibiting caspase-3, which is mediated by p44\/p42 mitogen-activated protein kinase","volume":"83","author":"Nakanishi","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.mam.2023.101225_bib164","first-page":"219","article-title":"Glaucoma \u2013 a neurodegenerative disease with cerebral neuroconnectivity elements","volume":"66","author":"Neac\u015fu","year":"2022","journal-title":"Rom J Ophthalmol"},{"key":"10.1016\/j.mam.2023.101225_bib165","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.397","article-title":"Non-amyloidogenic effects of \u03b12 adrenergic agonists: implications for brimonidine-mediated neuroprotection","volume":"7","author":"Nizari","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mam.2023.101225_bib166","doi-asserted-by":"crossref","first-page":"e820","DOI":"10.1038\/cddis.2013.341","article-title":"Inhibition of oxidative stress by coenzyme Q10 increases mitochondrial mass and improves bioenergetic function in optic nerve head astrocytes","volume":"4","author":"Noh","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mam.2023.101225_bib167","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00363","article-title":"Changes of visual pathway and brain connectivity in glaucoma: a systematic review","volume":"12","author":"Nuzzi","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.mam.2023.101225_bib168","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168565","article-title":"Exploring serum levels of brain derived neurotrophic factor and nerve growth factor across glaucoma stages","volume":"12","author":"Oddone","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2023.101225_bib169","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/14656566.2018.1544241","article-title":"Brimonidine tartrate for the treatment of glaucoma","volume":"20","author":"Oh","year":"2019","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.mam.2023.101225_bib170","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejphar.2012.06.035","article-title":"Oral administration of crocetin prevents inner retinal damage induced by N-methyl-d-aspartate in mice","volume":"690","author":"Ohno","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.mam.2023.101225_bib171","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.581136","article-title":"On the generation and regeneration of retinal ganglion cells","volume":"8","author":"Oliveira-Valen\u00e7a","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.mam.2023.101225_bib172","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0002-9394(02)01403-4","article-title":"Blindness and glaucoma: a comparison of patients progressing to blindness from glaucoma with patients maintaining vision","volume":"133","author":"Oliver","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib173","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-018-1041-8","article-title":"Neuroprotection of retinal ganglion cells by a novel gene therapy construct that achieves sustained enhancement of brain-derived neurotrophic factor\/tropomyosin-related kinase receptor-B signaling","volume":"9","author":"Osborne","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mam.2023.101225_bib174","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0006-8993(96)01393-5","article-title":"In vivo and in vitro experiments show that betaxolol is a retinal neuroprotective agent","volume":"751","author":"Osborne","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.mam.2023.101225_bib175","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/jop.2005.21.175","article-title":"Invited review: neuroprotective properties of certain beta-adrenoceptor antagonists used for the treatment of glaucoma","volume":"21","author":"Osborne","year":"2005","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.mam.2023.101225_bib176","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0006-8993(02)03951-3","article-title":"Protective effect of nilvadipine against glutamate neurotoxicity in purified retinal ganglion cells","volume":"961","author":"Otori","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.mam.2023.101225_bib177","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/09286586.2011.649228","article-title":"Glaucoma, alzheimer disease and other dementia: a longitudinal analysis","volume":"19","author":"Ou","year":"2012","journal-title":"Ophthalmic Epidemiol."},{"key":"10.1016\/j.mam.2023.101225_bib178","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/1120672118779486","article-title":"Evaluation of oxidative stress in pseudo-exfoliative glaucoma patients treated with and without topical coenzyme Q10 and vitamin E","volume":"29","author":"Ozates","year":"2019","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib179","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neulet.2007.02.090","article-title":"Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease","volume":"420","author":"Paquet","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.mam.2023.101225_bib180","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10633-005-7348-7","article-title":"Electrophysiological assessment of glaucomatous visual dysfunction during treatment with cytidine-5\u2019-diphosphocholine (citicoline): a study of 8 years of follow-up","volume":"110","author":"Parisi","year":"2005","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib181","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/IJG.0b013e318279b836","article-title":"Effects of coenzyme Q10 in conjunction with vitamin E on retinal-evoked and cortical-evoked responses in patients with open-angle glaucoma","volume":"23","author":"Parisi","year":"2014","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.mam.2023.101225_bib182","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00417-015-3044-9","article-title":"Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma","volume":"253","author":"Parisi","year":"2015","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib183","series-title":"Progress in Brain Research, Glaucoma: an Open Window to Neurodegeneration and Neuroprotection","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0079-6123(08)01137-0","article-title":"Evidence of the neuroprotective role of citicoline in glaucoma patients","author":"Parisi","year":"2008"},{"key":"10.1016\/j.mam.2023.101225_bib184","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0161-6420(99)90269-5","article-title":"Cytidine-5\u2032-diphosphocholine (citicoline) improves retinal and cortical responses in patients with glaucoma1","volume":"106","author":"Parisi","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.mam.2023.101225_bib185","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s12325-019-0897-z","article-title":"Enhancement of retinal function and of neural conduction along the visual pathway induced by treatment with citicoline eye drops in liposomal formulation in open angle glaucoma: a pilot electrofunctional study","volume":"36","author":"Parisi","year":"2019","journal-title":"Adv. Ther."},{"key":"10.1016\/j.mam.2023.101225_bib186","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2174\/1570159X15666170703111729","article-title":"Citicoline and retinal ganglion cells: effects on morphology and function","volume":"16","author":"Parisi","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.mam.2023.101225_bib187","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1167\/iovs.08-3013","article-title":"Effect of CNTF on retinal ganglion cell survival in experimental glaucoma","volume":"50","author":"Pease","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib188","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cca.2020.01.019","article-title":"Stress and neurodegeneration","volume":"503","author":"Pe\u00f1a-Bautista","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.mam.2023.101225_bib189","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3389\/fnins.2018.00834","article-title":"The role of endogenous neuroprotective mechanisms in the prevention of retinal ganglion cells degeneration","volume":"12","author":"Pietrucha-Dutczak","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.mam.2023.101225_bib190","series-title":"Progress in Brain Research, Glaucoma: A Neurodegenerative Disease of the Retina and beyond - Part A","first-page":"99","article-title":"Chapter 5 - the role of neuroinflammation in the pathogenesis of glaucoma neurodegeneration","author":"Pinazo-Dur\u00e1n","year":"2020"},{"key":"10.1016\/j.mam.2023.101225_bib191","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/02713683.2015.1004719","article-title":"Riluzole- and resveratrol-induced delay of retinal ganglion cell death in an experimental model of glaucoma","volume":"41","author":"Pirhan","year":"2016","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.mam.2023.101225_bib192","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/aos.14769","article-title":"Cholesterol and glaucoma: a systematic review and meta-analysis","volume":"100","author":"Posch-Pertl","year":"2022","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib193","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1167\/iovs.08-2656","article-title":"Coenzyme Q10 in the human retina","volume":"50","author":"Qu","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib194","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.survophthal.2021.02.003","article-title":"Glaucoma and neuroinflammation: an overview","volume":"66","author":"Quaranta","year":"2021","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib195","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib196","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2165\/00063030-200721030-00004","article-title":"Rho GTPase\/Rho kinase inhibition as a novel target for the treatment of glaucoma","volume":"21","author":"Rao","year":"2007","journal-title":"BioDrugs"},{"key":"10.1016\/j.mam.2023.101225_bib197","doi-asserted-by":"crossref","DOI":"10.1177\/1759091419871420","article-title":"Erythropoietin as a neuroprotective molecule: an overview of its therapeutic potential in neurodegenerative diseases","volume":"11","author":"Rey","year":"2019","journal-title":"ASN Neuro"},{"key":"10.1016\/j.mam.2023.101225_bib198","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s12035-015-9676-2","article-title":"Attenuation of axonal degeneration by calcium channel inhibitors improves retinal ganglion cell survival and regeneration after optic nerve crush","volume":"54","author":"Ribas","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.mam.2023.101225_bib199","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/biof.5520150104","article-title":"Induction of glutathione synthesis in human keratinocytes by Ginkgo biloba extract (EGb761)","volume":"15","author":"Rimbach","year":"2001","journal-title":"Biofactors"},{"key":"10.1016\/j.mam.2023.101225_bib200","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/sj.eye.6703071","article-title":"The effects of dorzolamide 2% and dorzolamide\/timolol fixed combination on retinal and optic nerve head blood flow in primary open-angle glaucoma patients","volume":"22","author":"Rolle","year":"2008","journal-title":"Eye"},{"key":"10.1016\/j.mam.2023.101225_bib201","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201701808","article-title":"Memantine-loaded PEGylated biodegradable nanoparticles for the treatment of glaucoma","volume":"14","author":"S\u00e1nchez-L\u00f3pez","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.mam.2023.101225_bib202","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev-neuro-071714-034120","article-title":"The types of retinal ganglion cells: current status and implications for neuronal classification","volume":"38","author":"Sanes","year":"2015","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.mam.2023.101225_bib203","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neuropharm.2013.07.034","article-title":"Three Ca2+ channel inhibitors in combination limit chronic secondary degeneration following neurotrauma","volume":"75","author":"Savigni","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mam.2023.101225_bib204","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1167\/iovs.09-4247","article-title":"Tumor necrosis factor-alpha concentrations in the aqueous humor of patients with glaucoma","volume":"51","author":"Sawada","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113977","article-title":"Structural and functional evidence for citicoline binding and modulation of 20S proteasome activity: novel insights into its pro-proteostatic effect","volume":"177","author":"Sbardella","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mam.2023.101225_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113977","article-title":"Structural and functional evidence for citicoline binding and modulation of 20S proteasome activity: novel insights into its pro-proteostatic effect","volume":"177","author":"Sbardella","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mam.2023.101225_bib207","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.3390\/ijms22115891","article-title":"Dexamethasone downregulates autophagy through accelerated turn-over of the ulk-1 complex in a trabecular meshwork cells strain: insights on steroid-induced glaucoma pathogenesis","volume":"22","author":"Sbardella","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib208","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033593","article-title":"Regulation of retinal proteome by topical antiglaucomatous eye drops in an inherited glaucoma rat model","volume":"7","author":"Schallenberg","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2023.101225_bib209","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1167\/iovs.07-1597","article-title":"Statins modulate heat shock protein expression and enhance retinal ganglion cell survival after transient retinal ischemia\/reperfusion in vivo","volume":"49","author":"Schmeer","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib210","article-title":"Endpoints for clinical trials in ophthalmology","volume":"101160","author":"Schmetterer","year":"2023","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.mam.2023.101225_bib211","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/jop.2014.0067","article-title":"Pharmacotherapy of glaucoma","volume":"31","author":"Schmidl","year":"2015","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.mam.2023.101225_bib212","doi-asserted-by":"crossref","first-page":"9445","DOI":"10.1021\/acsami.0c18626","article-title":"Improved treatment options for glaucoma with brimonidine-loaded lipid DNA nanoparticles","volume":"13","author":"Schnichels","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.mam.2023.101225_bib213","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/bs.pbr.2020.07.008","article-title":"Evidence on the neuroprotective properties of brimonidine in glaucoma","volume":"257","author":"Scuteri","year":"2020","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.mam.2023.101225_bib214","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.brainresbull.2009.11.004","article-title":"Limited restoration of visual function after partial optic nerve injury; a time course study using the calcium channel blocker lomerizine","volume":"81","author":"Selt","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.mam.2023.101225_bib215","first-page":"CD006539","article-title":"Neuroprotection for treatment of glaucoma in adults","volume":"1","author":"Sena","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.mam.2023.101225_bib217","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.exer.2016.07.006","article-title":"Topical administration of a Rock\/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury","volume":"158","author":"Shaw","year":"2017","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.mam.2023.101225_bib218","first-page":"799","article-title":"Ciliary neurotrophic factor in patients with primary open-angle glaucoma and age-related cataract","volume":"23","author":"Shpak","year":"2017","journal-title":"Mol. Vis."},{"key":"10.1016\/j.mam.2023.101225_bib219","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1089\/ars.2017.7290","article-title":"The role of sirtuins in antioxidant and redox signaling","volume":"28","author":"Singh","year":"2018","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.mam.2023.101225_bib220","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.ophtha.2012.04.029","article-title":"The relationship between statin use and open-angle glaucoma","volume":"119","author":"Stein","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.mam.2023.101225_bib221","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/1577","article-title":"Glutamate-induced neuron death requires mitochondrial calcium uptake","volume":"1","author":"Stout","year":"1998","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.mam.2023.101225_bib222","doi-asserted-by":"crossref","first-page":"7990","DOI":"10.1021\/acsami.6b16509","article-title":"Sustained release of brimonidine from a new composite drug delivery system for treatment of glaucoma","volume":"9","author":"Sun","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.mam.2023.101225_bib223","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejphar.2013.01.038","article-title":"Bimatoprost protects retinal neuronal damage via Akt pathway","volume":"702","author":"Takano","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.mam.2023.101225_bib224","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/cns.12187","article-title":"Activation of muscarinic receptors protects against retinal neurons damage and optic nerve degeneration in vitro and in vivo models","volume":"20","author":"Tan","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.mam.2023.101225_bib225","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.ophtha.2018.04.040","article-title":"Rho kinase inhibitors as a novel treatment for glaucoma and ocular hypertension","volume":"125","author":"Tanna","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.mam.2023.101225_bib226","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.3390\/ijms24043176","article-title":"Neuroprotection by drugs, nutraceuticals and physical activity","volume":"24","author":"Tarozzi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib227","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.mam.2023.101225_bib228","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators","volume":"130","author":"The Advanced Glaucoma Intervention Study (AGIS)","year":"2000","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib229","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0002-9394(98)00272-4","article-title":"The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group","volume":"126","year":"1998","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib230","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1523\/JNEUROSCI.1061-19.2019","article-title":"An annotated journey through modern visual neuroscience","volume":"40","author":"Trenholm","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mam.2023.101225_bib231","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3390\/cells10020295","article-title":"Targeting diet and exercise for neuroprotection and neurorecovery in glaucoma","volume":"10","author":"Tribble","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.mam.2023.101225_bib232","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101988","article-title":"Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction","volume":"43","author":"Tribble","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.mam.2023.101225_bib233","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcz035","article-title":"Midget retinal ganglion cell dendritic and mitochondrial degeneration is an early feature of human glaucoma","volume":"1","author":"Tribble","year":"2019","journal-title":"Brain Communications"},{"key":"10.1016\/j.mam.2023.101225_bib235","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108329","article-title":"Targeting immunoproteasome in neurodegeneration: a glance to the future","volume":"241","author":"Tundo","year":"2023","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.mam.2023.101225_bib236","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.3390\/cancers13194852","article-title":"At the cutting edge against cancer: a perspective on immunoproteasome and immune checkpoints modulation as a potential therapeutic intervention","volume":"13","author":"Tundo","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.mam.2023.101225_bib237","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107579","article-title":"The proteasome as a druggable target with multiple therapeutic potentialities: cutting and non-cutting edges","volume":"213","author":"Tundo","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.mam.2023.101225_bib238","series-title":"The Glaucoma Nicotinamide Trial - A Prospective, Randomized, Placebo-Controlled, Double-Masked Trial (Clinical Trial Registration No. NCT05275738)","year":"2022"},{"key":"10.1016\/j.mam.2023.101225_bib239","series-title":"Nicotinamide in Glaucoma (NAMinG): A Randomised, Placebo-Controlled, Multi-Centre, Phase III Trial (Clinical Trial Registration No. NCT05405868)","year":"2023"},{"key":"10.1016\/j.mam.2023.101225_bib240","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/1673-5374.283498","article-title":"Neuroprotective therapy for retinal neurodegenerative diseases by stem cell secretome","volume":"16","author":"Usategui-Martin","year":"2021","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.mam.2023.101225_bib241","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00417-018-3923-y","article-title":"The effect of trabeculectomy on serum brain-derived neurotrophic factor levels in primary open-angle glaucoma","volume":"256","author":"Uzel","year":"2018","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib242","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pneurobio.2015.06.002","article-title":"Towards axonal regeneration and neuroprotection in glaucoma: Rho kinase inhibitors as promising therapeutics","volume":"131","author":"Van de Velde","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.mam.2023.101225_bib243","article-title":"Citicoline eye drops protect trabecular meshwork cells from oxidative stress injury in a 3D in vitro glaucoma model","volume":"23","author":"Vernazza","year":"2022","journal-title":"Indian J. Manag. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib244","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/13543784.2020.1757647","article-title":"New targets and therapeutics for neuroprotection, remyelination and repair in multiple sclerosis","volume":"29","author":"Villoslada","year":"2020","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.mam.2023.101225_bib245","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0361-9230(03)00075-3","article-title":"Effects of axonal injury on ganglion cell survival and glutamate homeostasis","volume":"62","author":"Vorwerk","year":"2004","journal-title":"Brain Research Bulletin, Neuroprotection and the Eye"},{"key":"10.1016\/j.mam.2023.101225_bib246","first-page":"956","article-title":"Investigation of the neuroprotective effects of crocin via antioxidant activities in HT22 cells and in mice with Alzheimer's disease","volume":"43","author":"Wang","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.mam.2023.101225_bib247","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/759473","article-title":"The nerve growth factor signaling and its potential as therapeutic target for glaucoma","volume":"2014","author":"Wang","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.mam.2023.101225_bib248","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.mam.2023.101225_bib249","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1001\/archopht.117.11.1540","article-title":"Is neuroprotection a viable therapy for glaucoma?","volume":"117","author":"Weinreb","year":"1999","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib250","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.ophtha.2018.06.017","article-title":"Oral memantine for the treatment of glaucoma: design and results of 2 randomized, placebo-controlled, phase 3 studies","volume":"125","author":"Weinreb","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.mam.2023.101225_bib251","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.preteyeres.2011.11.005","article-title":"CNTF and retina","volume":"31","author":"Wen","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.mam.2023.101225_bib252","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/09286586.2017.1399427","article-title":"The influence of oral statin medications on progression of glaucomatous visual field loss: a propensity score analysis","volume":"25","author":"Whigham","year":"2018","journal-title":"Ophthalmic Epidemiol."},{"key":"10.1016\/j.mam.2023.101225_bib253","doi-asserted-by":"crossref","DOI":"10.1080\/19420889.2017.1356956","article-title":"Nicotinamide treatment robustly protects from inherited mouse glaucoma","volume":"11","author":"Williams","year":"2018","journal-title":"Commun. Integr. Biol."},{"key":"10.1016\/j.mam.2023.101225_bib254","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1126\/science.aal0092","article-title":"Vitamin B 3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice","volume":"355","author":"Williams","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.mam.2023.101225_bib255","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.3390\/ijms21176262","article-title":"Neuroprotection of retinal ganglion cells with AAV2-BDNF pretreatment restoring normal TrkB receptor protein levels in glaucoma","volume":"21","author":"W\u00f3jcik-Gryciuk","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib256","first-page":"2849","article-title":"Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension","volume":"42","author":"WoldeMussie","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib257","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/00061198-200212000-00003","article-title":"Neuroprotective effect of memantine in different retinal injury models in rats","volume":"11","author":"WoldeMussie","year":"2002","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.mam.2023.101225_bib258","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0014-4835(02)00335-4","article-title":"The beta-adrenoceptor antagonists metipranolol and timolol are retinal neuroprotectants: comparison with betaxolol","volume":"76","author":"Wood","year":"2003","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.mam.2023.101225_bib259","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/ICU.0000000000000558","article-title":"Retinal neuroprotection: current strategies and future directions","volume":"30","author":"Wubben","year":"2019","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib260","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1111\/bph.13492","article-title":"Antioxidant effects of resveratrol in the cardiovascular system","volume":"174","author":"Xia","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.mam.2023.101225_bib261","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brainres.2005.11.072","article-title":"Neuroprotective effect of calcium channel blocker against retinal ganglion cell damage under hypoxia","volume":"1071","author":"Yamada","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.mam.2023.101225_bib262","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.exer.2011.06.022","article-title":"Neuroprotective effects of prostaglandin analogues on retinal ganglion cell death independent of intraocular pressure reduction","volume":"93","author":"Yamagishi","year":"2011","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.mam.2023.101225_bib263","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejphar.2010.09.081","article-title":"Crocetin prevents retinal degeneration induced by oxidative and endoplasmic reticulum stresses via inhibition of caspase activity","volume":"650","author":"Yamauchi","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.mam.2023.101225_bib264","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1167\/iovs.17-22312","article-title":"Elevated intraocular pressure induces amyloid-\u03b2 deposition and tauopathy in the lateral geniculate nucleus in a monkey model of glaucoma","volume":"58","author":"Yan","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib265","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.molmed.2009.12.001","article-title":"Complement in neuroprotection and neurodegeneration","volume":"16","author":"Yanamadala","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.mam.2023.101225_bib266","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/00015385.2018.1549004","article-title":"Relationship between primary open angle glaucoma and blood pressure","volume":"75","author":"Yilmaz","year":"2020","journal-title":"Acta Cardiol."},{"key":"10.1016\/j.mam.2023.101225_bib267","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s10384-004-0156-x","article-title":"Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases","volume":"49","author":"Yoneda","year":"2005","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101225_bib268","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101364","article-title":"Associations of statin use with the onset and progression of open-angle glaucoma: a systematic review and meta-analysis","volume":"46","author":"Yuan","year":"2022","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.mam.2023.101225_bib269","first-page":"3216","article-title":"Atrophy of relay neurons in magno- and parvocellular layers in the lateral geniculate nucleus in experimental glaucoma","volume":"42","author":"Y\u00fccel","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2023.101225_bib270","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0006-8993(02)03735-6","article-title":"Effects of beta-adrenergic blockers on glutamate-induced calcium signals in adult mouse retinal ganglion cells","volume":"959","author":"Zhang","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.mam.2023.101225_bib271","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.lfs.2018.06.010","article-title":"Resveratrol ameliorates disorders of mitochondrial biogenesis and dynamics in a rat chronic ocular hypertension model","volume":"207","author":"Zhang","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.mam.2023.101225_bib272","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10571-007-9251-0","article-title":"Neuroprotection of muscarinic receptor agonist pilocarpine against glutamate-induced apoptosis in retinal neurons","volume":"28","author":"Zhou","year":"2008","journal-title":"Cell. Mol. Neurobiol."}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299723000651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299723000651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:27:18Z","timestamp":1789676838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299723000651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":267,"alternative-id":["S0098299723000651"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2023.101225","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel frontiers in neuroprotective therapies in glaucoma: Molecular and clinical aspects","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2023.101225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101225"}}